breast metastasis
Recently Published Documents


TOTAL DOCUMENTS

274
(FIVE YEARS 25)

H-INDEX

15
(FIVE YEARS 0)

2021 ◽  
Author(s):  
Ralph Khoury ◽  
Margot Bucau ◽  
Alexandra Bizot ◽  
Antoine Khalil

Breast Metastasis is a rare phenomenon (0.2 to 1.3%)1 compared to primary breast lesions. Several neoplasms have been reported to metastasize to the breast such as melanoma, lymphoma and lung cancer. In this article we report a case of breast metastasis of lung cancer confirmed by biopsy and immunohistochemistry with CT and US imaging.


Author(s):  
Amani Yousfi ◽  
Asma Ghorbel ◽  
Soufiene El Alami ◽  
Rim Abidi ◽  
Lina Kchaou ◽  
...  

2021 ◽  
Author(s):  
Yan Yang ◽  
Xiaomeng Yu ◽  
Miao Wang

Abstract BackgroundBenign and primary malignant breast tumors are quite common, but metastatic malignancies are rare and the diagnosis is challenging due to its low incidence.Case presentationHere, we report a case of metastatic melanoma which was initially diagnosed in breast by fine needle aspiration(FNA). Although the suggestive diagnosis is based on the strong pigmentation of tumor cells in FNA smears, cell block and immunohistochemical melanocyte markers (HMB45 and MART-1) help to confirm the diagnosis. Later, FNAs from lower limb mass and inguinal mass also revealed the same tumor. In addition, a pigmented nevus with the appearance of malignant melanoma was found on the sole of the patient's right foot.Conclusion Our report illustrates the morphological evaluation on cytology,ancillary testing on cell block and meticulous clinical examination play a pivotal role in establishing the correct diagnosis.


2021 ◽  
Author(s):  
N Doan ◽  
T Nguyen ◽  
L Ta ◽  
Y Nguyen ◽  
T Thai ◽  
...  

2021 ◽  
Vol 429 ◽  
pp. 118434
Author(s):  
Sirine Belghuith ◽  
Khadija Sonda Moalla ◽  
Nouha Farhat ◽  
Olfa Hdiji ◽  
Salma Sakka ◽  
...  

2021 ◽  
Vol 33 (3) ◽  
pp. 226-228
Author(s):  
Dan -Dan Wang ◽  
Su -Jin Yang ◽  
Wei -Xian Chen ◽  
Wei -Xian Chen

BackgroundMetastasis from extramammary primary tumor to breast is extremely rare. Case SummaryA 59-year-old woman with 1-year history of rectal cancer presented with asymptomatic breast mass. At 16 months after the diagnosis of rectal mucinous adenocarcinoma, a breast mass was confirmed by ultrasonography and identified by pathology and immunohistochemistry as a metastasis from the rectal cancer. Treatments included chemotherapy (6 cycles: 300 mg irinotecan on day 1, 4.5 mg raltitrexed on day 2, 450 mg bevacizumab on day 3), radiotherapy, and surgical resection. Two years of follow-up examinations (6-months intervals) showed no evidence of recurrence or novel distant metastasis. ConclusionBreast metastasis from rectal carcinoma is a rare secondary malignancy. Final diagnosis can be established by histopathology and immunohistochemistry.


Author(s):  
Laiba Masood ◽  
Sana Sayeed ◽  
Samreen Aslam

Abstract Background Breast metastasis in hematological malignancies is a rare phenomenon, and it is primarily seen in acute myeloid leukemia (AML). In patients with acute lymphoblastic leukemia (ALL), this condition is even rarer. Case presentation. We present a case of a precursor B cell ALL involving breast in a 40-year-old female and its imaging features on mammography and ultrasound. Histopathology of core needle biopsy (CNB) specimen allowed us to diagnose ALL with extramedullary metastases. The patient was referred to oncology for further management. Conclusion To conclude, ALL infiltrating breast is rare but should be given due consideration, especially in the cases of known primary hematopoietic malignancy, particularly in patients presenting with a history of sudden lumps in the breast. A CNB can give reliable results in combination with flow cytometry and immunocytochemistry, circumventing the need for an excisional biopsy and allowing the commencement of early treatment.


2021 ◽  
Vol 28 (5) ◽  
pp. 3384-3392
Author(s):  
Carmine Valenza ◽  
Francesca Maria Porta ◽  
Alessandra Rappa ◽  
Elena Guerini-Rocco ◽  
Giuseppe Viale ◽  
...  

We present a case of a woman with epidermal growth factor receptor (EGFR)-mutated lung adenocarcinoma who received gefitinib for 2 years and obtained a partial response. The patient then developed liver metastasis and a breast lesion, displaying high estrogen receptor (ER) expression and harboring the same EGFR mutation. From the radiological studies, it was not possible to make a differential diagnosis between primary breast cancer and breast metastasis from lung cancer. After the removal of the breast nodule, thanks to the clinical history, radiology, and above all, molecular and immunohistochemical investigations, a diagnosis of breast metastasis from lung adenocarcinoma was made. This case emphasizes the importance of a comprehensive clinical, pathological, and molecular analysis in the differential diagnosis between primary breast cancer and metastases from extramammary tumor to guide adequate treatment decision making.


2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Yoko Omi ◽  
Hidenori Kamio ◽  
Yusaku Yoshida ◽  
Kenta Masui ◽  
Tomoko Yamamoto ◽  
...  

Abstract Background Metastasis to the breast is rare. We herein report a patient with metastatic medullary thyroid carcinoma to the breast for whom measuring the calcitonin level was an important clue to the correct diagnosis. Case presentation A 54-year-old woman visited our hospital for the treatment of recurrent metastatic medullary thyroid carcinoma due to multiple endocrine neoplasia 2A and breast cancer. Positron emission tomography performed before the operation for metastatic medullary thyroid carcinoma recurrence in the neck showed the accumulation of 18F-fluorodeoxyglucose in the bilateral breast at sites other than the disease in the neck. Ultrasonography revealed multiple tumors in both breasts. A core needle biopsy of three breast tumors was performed. Microscopically, the tumor cells showed solid growth and did not show a tubular structure. She was diagnosed with triple-negative invasive ductal carcinoma. Post-operative positron emission tomography was performed as the serum calcitonin level increased after the operation. The accumulation of 18F-fluorodeoxyglucose in the bilateral breast tumors and lymph nodes in the neck was noted. The possibility of the breast tumors being metastasis of metastatic medullary thyroid carcinoma was considered. Needle aspiration was performed for three breast tumors. The calcitonin level of the washout fluid was measured and found to be ≥ 17,500 pg/mL. Immunohistochemistry showed that the tumor cells were calcitonin-positive and gross cystic disease fluid protein-15-negative. Vandetanib was started as recurrent metastatic medullary thyroid carcinoma with breast metastasis was finally diagnosed. The serum calcitonin level decreased after 1 month. Conclusion Although breast metastasis of medullary thyroid carcinoma is rare, a correct diagnosis is indispensable for appropriate treatment. When a breast tumor shows atypical morphological features for breast cancer according to the histopathology in a patient with a history of cancer, metastasis to the breast should be considered. Calcitonin measurement of the needle washout fluid was useful for confirming metastatic medullary thyroid carcinoma.


Sign in / Sign up

Export Citation Format

Share Document